Literature DB >> 20651334

Alpha terpineol: a potential anticancer agent which acts through suppressing NF-kappaB signalling.

Saadia Bashir Hassan1, Hala Gali-Muhtasib, Hanna Göransson, Rolf Larsson.   

Abstract

BACKGROUND: Alpha terpineol is a bioactive component of Salvia libanotica essential oil extract and has shown antitumour activity.
MATERIALS AND METHODS: The cytotoxicity of alpha terpineol towards different tumour cell lines was evaluated in vitro. Mechanistic characterization was performed using analysis of drug activity in a cell line panel and drug-induced gene expression perturbation using the connectivity map approach.
RESULTS: The small cell lung carcinoma was the cell line most sensitive to alpha terpineol. The results proposed alpha terpineol as an NF-kappaB inhibitor, which was confirmed by the observed dose-dependent inhibition of NF-kappaB translocation and activity using two NF-kappaB assays, and by the down-regulation of the expression of several NF-kappaB-related genes such as IL-1 beta and IL1R1.
CONCLUSION: The results suggest that alpha terpineol inhibits the growth of tumour cells through a mechanism that involves inhibition of the NF-kappaB pathway.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20651334

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  28 in total

1.  A new class of bacterial quorum sensing antagonists: glycomonoterpenols synthesized using linalool and alpha terpineol.

Authors:  Ruchira Mukherji; Asmita Prabhune
Journal:  World J Microbiol Biotechnol       Date:  2015-05-01       Impact factor: 3.312

2.  An in vitro study of the antifungal activity of Trichoderma virens 7b and a profile of its non-polar antifungal components released against Ganoderma boninense.

Authors:  Lee Pei Lee Angel; Mohd Termizi Yusof; Intan Safinar Ismail; Bonnie Tay Yen Ping; Intan Nur Ainni Mohamed Azni; Norman Hj Kamarudin; Shamala Sundram
Journal:  J Microbiol       Date:  2016-10-29       Impact factor: 3.422

3.  Identifying inhibitors of epithelial-mesenchymal transition by connectivity map-based systems approach.

Authors:  Ajaya Kumar Reka; Rork Kuick; Himabindu Kurapati; Theodore J Standiford; Gilbert S Omenn; Venkateshwar G Keshamouni
Journal:  J Thorac Oncol       Date:  2011-11       Impact factor: 15.609

4.  PEGylated Lecithin-Chitosan Nanoparticle-Encapsulated Alphα-Terpineol for In Vitro Anticancer Effects.

Authors:  Bahar Zarei; Masoud Homayouni Tabrizi; Amir Rahmati
Journal:  AAPS PharmSciTech       Date:  2022-03-21       Impact factor: 3.246

5.  An In Silico Investigation to Explore Anti-Cancer Potential of Foeniculum vulgare Mill. Phytoconstituents for the Management of Human Breast Cancer.

Authors:  Baljinder Kaur; Rajan Rolta; Deeksha Salaria; Balvir Kumar; Olatomide A Fadare; Renato Araujo da Costa; Ajaz Ahmad; Mahmood Basil A Al-Rawi; Mohammad Raish; Irfan A Rather
Journal:  Molecules       Date:  2022-06-24       Impact factor: 4.927

6.  In vivo antitumor potential of Ipomoea pes-caprae on melanoma cancer.

Authors:  Ashish Manigauha; M D Kharya; N Ganesh
Journal:  Pharmacogn Mag       Date:  2015 Apr-Jun       Impact factor: 1.085

Review 7.  Antitumor activity of monoterpenes found in essential oils.

Authors:  Marianna Vieira Sobral; Aline Lira Xavier; Tamires Cardoso Lima; Damião Pergentino de Sousa
Journal:  ScientificWorldJournal       Date:  2014-10-14

Review 8.  Essential oils and their constituents as anticancer agents: a mechanistic view.

Authors:  Nandini Gautam; Anil K Mantha; Sunil Mittal
Journal:  Biomed Res Int       Date:  2014-06-09       Impact factor: 3.411

Review 9.  Wound Healing: Biologics, Skin Substitutes, Biomembranes and Scaffolds.

Authors:  Krishna S Vyas; Henry C Vasconez
Journal:  Healthcare (Basel)       Date:  2014-09-10

10.  Decatropis bicolor (Zucc.) Radlk essential oil induces apoptosis of the MDA-MB-231 breast cancer cell line.

Authors:  C C Estanislao Gómez; A Aquino Carreño; D G Pérez Ishiwara; E San Martín Martínez; J Morales López; N Pérez Hernández; M C Gómez García
Journal:  BMC Complement Altern Med       Date:  2016-08-05       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.